D. E. Shaw & Co., Inc. Chimerix Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.87 - $1.05 $83,529 - $100,811	-96,011 Reduced 25.63%	278,615 $245,000
Q1 2024 May 15, 2024	BUY	$0.91 - $1.26 $93,781 - $129,851	103,057 Added 37.95%	374,626 $397,000
Q4 2023 Feb 14, 2024	BUY	$0.9 - $1.06 $19,503 - $22,971	21,671 Added 8.67%	271,569 $260,000
Q3 2023 Nov 14, 2023	SELL	$0.94 - $1.23 $78,006 - $102,072	-82,986 Reduced 24.93%	249,898 $239,000
Q2 2023 Aug 14, 2023	SELL	$1.1 - $1.54 $164,360 - $230,105	-149,419 Reduced 30.98%	332,884 $402,000
Q1 2023 May 15, 2023	SELL	$1.19 - $2.09 $202,749 - $356,090	-170,378 Reduced 26.1%	482,303 $607,000
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.35 $192,931 - $271,490	-115,528 Reduced 15.04%	652,681 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $116,169 - $177,142	64,182 Added 9.12%	768,209 $1.48 Million
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $743,147 - $2.96 Million	554,588 Added 371.11%	704,027 $1.46 Million
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $2,468 - $3,665	-539 Reduced 0.36%	149,439 $684,000
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $95,829 - $131,559	18,323 Added 13.92%	149,978 $965,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $215,538 - $317,502	-36,286 Reduced 21.61%	131,655 $815,000
Q2 2021 Aug 16, 2021	SELL	$7.54 - $9.79 $137,680 - $178,765	-18,260 Reduced 9.81%	167,941 $1.34 Million
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $1.48 Million - $3.5 Million	-311,479 Reduced 62.59%	186,201 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$2.43 - $5.42 $22,744 - $50,731	9,360 Added 1.92%	497,680 $2.4 Million
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $115,747 - $187,209	-50,325 Reduced 9.34%	488,320 $1.22 Million
Q2 2020 Aug 14, 2020	SELL	$1.33 - $3.63 $101,723 - $277,636	-76,484 Reduced 12.43%	538,645 $1.67 Million
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $378,203 - $693,869	-297,798 Reduced 32.62%	615,129 $886,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $301,514 - $630,860	231,934 Added 34.06%	912,927 $1.85 Million
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $303,401 - $661,824	157,203 Added 30.01%	680,993 $1.6 Million
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $612,755 - $1.29 Million	-298,905 Reduced 36.33%	523,790 $2.26 Million
Q1 2019 May 15, 2019	BUY	$1.79 - $3.12 $292,487 - $509,811	163,401 Added 24.78%	822,695 $1.73 Million
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $232,509 - $404,816	103,799 Added 18.69%	659,294 $1.7 Million
Q3 2018 Nov 14, 2018	BUY	$3.58 - $4.9 $171,120 - $234,215	47,799 Added 9.41%	555,495 $2.16 Million
Q2 2018 Aug 14, 2018	BUY	$4.43 - $5.14 $196,926 - $228,488	44,453 Added 9.6%	507,696 $2.42 Million
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $72,205 - $91,615	15,528 Added 3.47%	463,243 $2.41 Million
Q4 2017 Feb 14, 2018	SELL	$4.32 - $5.52 $163,939 - $209,478	-37,949 Reduced 7.81%	447,715 $2.07 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $2.11 Million - $2.55 Million	485,664	485,664 $2.55 Million

Others Institutions Holding CMRX

# of Institutions

Shares Held

37M

Call Options Held

52.7K

Put Options Held

130K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$7.74 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

4.33M
Shares

$3.81 Million
0.0% of portfolio
Monaco Asset Management Sam

4.22M
Shares

$3.71 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.4M
Shares

$2.11 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.21M
Shares

$1.94 Million
0.03% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account